Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025

This bill requires Medicare to only cover nerve conduction studies and needle electromyography tests at facilities meeting specific quality standards. To qualify, facilities must be accredited by an organization that verifies they have a quality program, use approved equipment, ensure staff have proper training, and interpret results on-site during procedures. Starting 3-4 years after enactment, Medicare will not pay for these services at non-compliant facilities. The bill also establishes an advisory committee to help develop and update these standards, aiming to improve care quality and reduce fraud.